Healthcare Technology Transformation Sensors Wearables and Personalized Medicine Reshaping Clinical Care
Weak Market Breadth Sidelines Nifty as Consolidation Persists
Advanced Painting Pty Ltd Highlights Key Residential Painting Challenges and Repainting Trends in Sydney
Inflation Pressure Broadens Beyond Oil and Iran Prices Accelerate in Services Rent and Food
BP Removes Chairman Albert Manifold Amid Board Complaints
Reddit Shares Slide Nearly 6 on Metas Launch of Competing Forum App
OOMA Q1 2026 Earnings EPS Surpasses Estimates by 929
Health In Tech Inc HIT Q1 2026 Earnings Narrow Loss Beat Expectations Stock Dips 26 on Absent Revenue Details
KGC Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds
GOODN Q1 2026 Earnings Preferred Stock Reports Strong EPS Surprise
Pure Cycle Corporation PCYO Q1 2026 Earnings Earnings Per Share of 005 Amidst No Consensus Estimate
LAR Q1 2026 Earnings EPS Misses Estimates as Development Continues
Mobix Labs MOBX Rebounds Testing Key Resistance at 229 Amidst Sector Rotation
Vishay Intertechnology VSH Surges 66 as Momentum Builds Above Key Support
Structure Therapeutics GPCR Posts Marginal Decline Eyes Key Support Levels
Quad Graphics QUAD Shares Rise on AboveAverage Volume Key Levels in Focus
STAK Inc STAK Slides Toward Key Support After 455 Decline
Artisan Value Fund Sells Diageo Stake Amid First Quarter Portfolio Shifts
IGC Q1 2026 Earnings Narrowing Losses as Cost Discipline Drives EPS Beat
WidePoint Corporation WYY Surges 11 as Support Holds Strong
JBLU JetBlue Airways Corporation reports wider than expected Q4 2025 loss as shares rise more than six percent
Alphabet GOOG Investment Strategy Q4 2025 Better Than Expected
Macys M Stock Why Insiders Bought It 037 20260416
IQ iQIYI Inc American Depositary Shares posts narrower than expected Q4 2025 loss even as revenue drops 66 percent year over year
AIO Virtus AI reports quarterly results with key financial metrics not disclosed amid structural fund assessment
The real value proposition of CVS Health CVS stock 058 20260507
ESLA Estrella Immunopharma Inc reports wider than expected Q1 2026 EPS loss but shares rise 13 percent in regular trading